Inotersen
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Inotersen, covering 2019-01-23 to 2026-02-20. Get the full timeline:
Most recent: Clinical Trial Update: 24 Month Open Label Study of the Tolerability and Efficacy of Inotersen in TTR Amyloid Cardiomyopathy Patients [Phase 2]